Deepening Digitalization in Drug Discovery at PTC Therapeutics
Posted: 4 March 2025 | | No comments yet
PTC Therapeutics accelerates drug discovery process by integrating physicochemical property predictions into their Dotmatics ELN.
Learn how PTC Therapeutics accelerated their drug discovery process through the integration of property predictions into their Dotmatics ELN. This digitalization approach has enabled high-throughput screening, seamless data access, and efficient decision-making, enhancing collaboration, and accelerating innovation in developing therapies for rare genetic diseases.
Related content from this organisation
Related topics
Biopharmaceuticals, Chromatography, Drug Development, Formulation, Lab Automation, Research & Development (R&D), Therapeutics